Supervised morphogenesis in gastruloids
This project aims to develop advanced gastruloid technology to create larger, vascularized organ models that better mimic human physiology, reducing reliance on animal experiments.
Projectdetails
Introduction
The lack of realistic in vitro organ models that can faithfully represent in vivo physiological processes is a major obstacle affecting the biological and medical sciences. The current gold standard is animal experiments, but it is increasingly clear that these models mostly fail to recapitulate human physiology.
Controversy of Animal Experiments
Moreover, animal experiments are controversial, and it is a common goal in the scientific community to minimize the use of animals to a strictly necessary minimum.
Emergence of Organoids
The emergence of stem cell engineered organ models called organoids represents the only viable alternative to animal research. However, current organoid technology is yet to produce the larger physiologically relevant organ models that the medical sciences really need.
Limitations of Current Organoids
Specifically, current organoids are:
- Too small
- Not vascularized
- Lacking the 3-dimensional organization found in vivo
Project Goals
In this interdisciplinary project, we aim to challenge all these limitations by using the recently developed gastruloid technology guided by cutting-edge bioengineering and artificial intelligence.
Gastruloids Overview
Gastruloids are formed by initiating the very early developmental processes and develop along a highly coordinated three axial process that closely resembles mammalian embryogenesis. Moreover, gastruloids can develop several organ precursors simultaneously and thus constitute important improvements over conventional single-tissue organoids.
Research Methodology
To harness the potential of gastruloid technology, we will:
- Implement large sequencing and imaging experiments to optimize the developmental trajectory of gastruloids for organ inductions.
- Build these datasets into a multimodal data matrix to identify gastruloid candidates for cardiovascular and foregut development.
Identification of Candidates
Specifically, we will identify candidates that show strong vasculogenesis as candidates for later vascularization by anastomosing with endothelial cells.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 3.337.725 |
Totale projectbegroting | € 3.438.217 |
Tijdlijn
Startdatum | 1-11-2022 |
Einddatum | 31-10-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- OSLO UNIVERSITETSSYKEHUS HFpenvoerder
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
- FORSCHUNGSVERBUND BERLIN EV
- TEL AVIV UNIVERSITY
- UNIVERSITETET I OSLO
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
- UNIVERSITY OF GLASGOW
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
Dynamic Spatio-Temporal Modulation of Light by Phononic ArchitecturesDynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements. | EIC Pathfinder | € 2.552.277 | 2022 | Details |
Emerging technologies for crystal-based gamma-ray light sourcesTECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology. | EIC Pathfinder | € 2.643.187 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Dynamic Spatio-Temporal Modulation of Light by Phononic Architectures
Dynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements.
Emerging technologies for crystal-based gamma-ray light sources
TECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughputHEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments. | ERC COG | € 2.969.219 | 2022 | Details |
An automated platform for the large-scale production of miniaturized neuromuscular organoidsThe project aims to automate and scale the production of complex neuromuscular organoids for high-throughput drug screening to advance therapies for neuromuscular diseases. | ERC POC | € 150.000 | 2023 | Details |
Coupling morphogen dynamics with mechanics in the control of form and patternThis project aims to uncover how morphogen dynamics and mechanical properties interact to coordinate patterning and morphogenesis in zebrafish and human gastruloids, with broader implications for biology and medicine. | ERC STG | € 1.500.000 | 2024 | Details |
Engineering the Origin of Human Shape: Defining Patterns and Axes in the Early Stage of 3D PluripotencyOriSha aims to revolutionize in vitro human embryonic development modeling by using a hydrogel-microfluidic system to control biochemical signals for studying neural tube morphogenesis. | ERC STG | € 1.499.633 | 2024 | Details |
3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughput
HEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments.
An automated platform for the large-scale production of miniaturized neuromuscular organoids
The project aims to automate and scale the production of complex neuromuscular organoids for high-throughput drug screening to advance therapies for neuromuscular diseases.
Coupling morphogen dynamics with mechanics in the control of form and pattern
This project aims to uncover how morphogen dynamics and mechanical properties interact to coordinate patterning and morphogenesis in zebrafish and human gastruloids, with broader implications for biology and medicine.
Engineering the Origin of Human Shape: Defining Patterns and Axes in the Early Stage of 3D Pluripotency
OriSha aims to revolutionize in vitro human embryonic development modeling by using a hydrogel-microfluidic system to control biochemical signals for studying neural tube morphogenesis.